Clinical Trial Update: Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 pilot study assessing the efficacy and safety of quetiapine fumarate immediate-release (Seroquel IR) for controlling agitation and aggressive behaviors …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Seroquel IR (quetiapine fumarate)

Snippet

Sponsor: Sichuan University | Conditions: Acute Schizophrenia | Phase 4 | Status: UNKNOWN